REGULATION OF CARDIAC CONTRACTILITY AND HEART FAILURE PROPENSITY
摘要
The methods and compositions of the present invention find use in altering expression of PKCalpha in transgenic animals. The compositions of the invention include isolated transgenic animal cells, transgenic tissue, and transgenic mice. The transgenic animals of the invention exhibit altered PKCalpha activity. The methods allow generation of transgenic animals with altered expression of PKCalpha. The invention allows modulation of cardiac contractility. In particular, the invention provides a method for altering the susceptibility of a transgenic animal to cardiomyopathy. A transgenic animal of the invention finds use in identifying anti-cardiomyopathic compounds.
申请公布号
WO2005027629(A3)
申请公布日期
2006.04.06
申请号
WO2004US30581
申请日期
2004.09.17
申请人
CHILDREN'S HOSPITAL MEDICAL CENTER;UNIVERSITY OF CINCINNATI;MOLKENTIN, JEFFERY, DANIEL;KRANIAS, EVANGELIA, GALANI